Table 1.

Patient data

No.AgeTumor-node-metastasis stageTumor size (cm) max. diameterSUV tumorSUV LNStaining pattern IHC αvβ3*
150pT1 pN2b cM0 G20.2n.d.4.00Tumor vessels in lymph node metastasis positive; ++
235pT3 pN0 cM0 G22.03.80Tumor vessels positive; +
359pT1 pN0 cM0 G11.43.10Tumor vessels positive; +
442mcT3 cN0 cM0 G33.05.80Tumor vessels and cells positive; ++
1.83.57
561pT1 pN1 cM0 G21.02.38n.d.Tumor vessels positive; +
659pT2 pN1 cM0 G24.55.26n.d.Tumor vessels positive; ++
759pT2 pN0 cM0 G24.03.25Tumor vessels positive; ++
852mpT1 pN0 cM0 G10.1/0.3n.d.
963cT3 cN2c cM0 G32.02.75n.d.
1055cT3 cN2c cM1 G33.02.202.05
1158cT3 cN1 cM0 G33.22.30n.d.
  • Abbreviations: LN, lymph node; IHC, immunohistochemistry; n.d., lesion not depicted by [18F]Galacto-RGD PET.

  • * Overall staining intensity: 0, negative; +, weak; ++, moderate; +++, intense staining.